Post by Yelk on Feb 26, 2015 4:26:02 GMT
I don't want to spam the forum with new stocks so I'll try to make this one my last for a long time but I found this one very interesting and am starting DD on it.
-No Debt
-Yes could face cash issues long term
-P2 data March 2015
-P2 Data June 2015
-P2 Data Dec 2015
The chart is disgusting. Everyone is bearish. I am intrigued.
Why?
1) I believe we are at the bottom of the chart similar to ATHX and NVIV at $.50.
2) We have multiple data read outs coming, one very soon
3) Positive data from prior trials, bad market reaction (was good but not what expecting)
4) CEO has been loading up on stocks with 13 recent buys
I think from the nature of the science I've learned so far I can see why the market has over reacted to data presented. It is hard to interpret what exactly it means. From these levels with one or two positive data read outs with the recent acquisitions and new management changes. I need to do a full look at data and science but for now my interest is peaked for speculative opportunity here in oversold territory.
The trials can be found here www.rxipharma.com/clinical-trials/
I'd recommend reading this articles:
seekingalpha.com/symbol/RXII
This one with the CEO in particular explains about the share price
seekingalpha.com/article/2514825-rxi-pharmaceuticals-interview-with-ceo-post-phase-2a-interim-data
Cheers, GL all with your investments.
-No Debt
-Yes could face cash issues long term
-P2 data March 2015
-P2 Data June 2015
-P2 Data Dec 2015
The chart is disgusting. Everyone is bearish. I am intrigued.
Why?
1) I believe we are at the bottom of the chart similar to ATHX and NVIV at $.50.
2) We have multiple data read outs coming, one very soon
3) Positive data from prior trials, bad market reaction (was good but not what expecting)
4) CEO has been loading up on stocks with 13 recent buys
I think from the nature of the science I've learned so far I can see why the market has over reacted to data presented. It is hard to interpret what exactly it means. From these levels with one or two positive data read outs with the recent acquisitions and new management changes. I need to do a full look at data and science but for now my interest is peaked for speculative opportunity here in oversold territory.
The trials can be found here www.rxipharma.com/clinical-trials/
I'd recommend reading this articles:
seekingalpha.com/symbol/RXII
This one with the CEO in particular explains about the share price
seekingalpha.com/article/2514825-rxi-pharmaceuticals-interview-with-ceo-post-phase-2a-interim-data
Cheers, GL all with your investments.
